Oncoliq
Oncoliq is a biotechnology startup focused on revolutionizing cancer detection through its proprietary liquid biopsy technology. The company leverages molecular biology and machine learning to identify microRNAs in blood samples, enabling early, non-toxic, and low-cost cancer detection. Their process involves annual checkups, blood extraction, microRNA isolation, Oncoliq detection, and informed early detection if positive. Oncoliq's technology is sensitive enough for patient follow-up during and after treatment. The company aims to significantly reduce cancer-related deaths worldwide by making early detection accessible and widespread. They collaborate with numerous hospitals and research institutions in Argentina.
Oncoliq
Oncoliq is a biotechnology startup focused on revolutionizing cancer detection through its proprietary liquid biopsy technology. The company leverages molecular biology and machine learning to identify microRNAs in blood samples, enabling early, non-toxic, and low-cost cancer detection. Their process involves annual checkups, blood extraction, microRNA isolation, Oncoliq detection, and informed early detection if positive. Oncoliq's technology is sensitive enough for patient follow-up during and after treatment. The company aims to significantly reduce cancer-related deaths worldwide by making early detection accessible and widespread. They collaborate with numerous hospitals and research institutions in Argentina.